Two Analysis Group Studies Named “Editor’s Choice” by the Journal of Medical Economics and Journal of Clinical Pathways

March 22, 2023

The editors-in-chief for the Journal of Medical Economics (JME) and the Journal of Clinical Pathways selected separate studies coauthored by Analysis Group researchers for their respective year-end “Editor’s Choice” recognition.

Kenneth KC Lee, JME’s Editor-in-Chief, selected “Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective” as one of his top picks for papers published in 2022. The study was coauthored by Analysis Group Managing Principals Annie Guérin and Patrick Lefebvre, Vice Presidents Martin Cloutier and Patrick Gagnon-Sanschagrin, and Senior Research Professionals Mikhail Davidson and Frederic Kinkead, along with researchers from Otsuka Pharmaceutical, the NYU Grossman School of Medicine, and the Center for Psychiatry and Behavioral Medicine in Las Vegas.

Journal of Clinical Pathways Editor-in-Chief Winston Wong listed “The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences” first among “the top 5 research reports the Journal published in 2022 that our audience found most compelling.” The study’s coauthors included Managing Principal Annie Guérin and Managers Nisha Hazra and Honghao Fang, working with researchers from the Dana-Farber Cancer Institute, the University of Washington and Fred Hutchinson Cancer Research Center, Genentech, and AbbVie.

Analysis Group congratulates the authors on their accomplishments.

Read the JME’s blog post here

Read the Journal of Clinical Pathways article here